BiotechTube
Nordic Pharma

Nordic Pharma

Paris, France· Est.
nordicpharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Nordic Pharma is a medium-sized, privately-held international pharmaceutical company with over 30 years of operational history, headquartered in Paris, France. It has built a commercial portfolio across Women's Health, Rheumatology, and Ophthalmology, supported by a global footprint of affiliates and partners. The company is in a revenue-generating, commercial stage, leveraging a strategy of targeted acquisitions and in-licensing to address niche therapeutic areas with high unmet needs.

Women's HealthRheumatologyOphthalmologyCritical Care

Technology Platform

Business development and commercialization platform focused on acquiring and developing late-stage/commercial-stage assets in specialized therapeutic areas.

Opportunities

The European launch and further global rollout of Lacrifill® provides immediate growth in the large ophthalmology market.
Further acquisitions in core franchises (Rheumatology, Women's Health) can deepen market presence.
Leveraging its global partner network offers a capital-efficient path to expand into new geographic markets.

Risk Factors

Revenue dependence on a concentrated portfolio of products and franchises creates vulnerability to competition or regulatory issues.
Growth is contingent on the ongoing success of its acquisition strategy, which carries execution and integration risks.
Navigating diverse regulatory and reimbursement environments across its global footprint presents an ongoing challenge.

Competitive Landscape

Nordic Pharma competes in specialized niches against both large pharmaceutical companies with broader portfolios and other mid-sized, focused specialty pharma firms. Its competitive edge lies in its agility, deep therapeutic area expertise, and hybrid model of owned affiliates and distribution partners. In areas like Women's Health, it may face competition from both generic and branded products.

More companies in Small Molecule Drugs →More companies in France →